The European Veterinary Industry: Market Insights and Trends

The European veterinary industry has developed into one of the world’s most important animal health markets. Driven by structural changes such as increased pet ownership, higher expectations around animal welfare, and a growing focus on preventive care, the sector continues to expand and professionalise across Europe.
For international companies, Europe represents a diverse but attractive veterinary market, shaped by country‑specific regulations, consumer behaviour, and veterinary practices. This article explores the key drivers, market dynamics, and long‑term trends shaping the European veterinary industry.
How is the European veterinary market structured?
Europe is one of the largest animal health markets globally, with strong participation from companion animal, livestock, and veterinary pharmaceutical segments. Companion animal care plays an increasingly central role, supported by high pet ownership rates in major markets such as Germany, France, and the United Kingdom.
Rather than being driven by short‑term trends, growth in the European veterinary market is rooted in long‑term lifestyle and demographic changes, including urbanisation, smaller households, and close emotional bonds between pet owners and their animals.
Why is pet healthcare demand increasing in Europe?
Pet life expectancy has increased significantly due to advances in veterinary medicine, diagnostics, and treatment options. As animals live longer, demand for ongoing medical care, diagnostics, pharmaceuticals, and preventive treatments increases.
Veterinary care in Europe includes a wide range of products and services such as vaccinations, parasiticides, antibiotics, surgical procedures, and wellness programmes. Preventive care has become a central pillar of veterinary practice, reflecting both clinical best practices and owner expectations around long‑term health outcomes.
Public investment in veterinary infrastructure, alongside private clinic expansion, continues to support access to veterinary services across the region.
Which countries lead the European veterinary industry?
Germany, France, the United Kingdom, and Spain are among the strongest veterinary markets in Europe.
Germany is widely recognised for its veterinary research and development ecosystem and is home to multiple global animal health and pharmaceutical firms. Strong consumer spending on pet care and a well‑developed veterinary clinic network support sustained demand.
France places high priority on animal health and welfare, supported by established regulatory bodies and veterinary research institutions. The country plays an important role in veterinary medicinal evaluation and market oversight.
The United Kingdom remains a key companion‑animal market, characterised by advanced clinical practices, strong demand for preventive care, and high levels of pet insurance adoption.
What trends are shaping the European veterinary industry?
1. Pet adoption is driving long‑term growth
Rising pet adoption across Europe has created a structural increase in demand for veterinary services. As more households adopt pets, veterinary care transitions from episodic treatment to ongoing health management.
Pet “humanisation”, where pets are treated as family members, continues to influence spending behaviour, encouraging owners to invest in diagnostics, advanced treatments, and preventive care throughout an animal’s life.
2. Preventive care is gradually increasing in importance
Preventive care has gained prominence as veterinary professionals and owners recognise its role in improving long‑term outcomes and reducing the incidence of complex disease.
Vaccination programmes, regular health screenings, parasite prevention, and wellness plans are now widely integrated into routine veterinary care across Europe. This shift supports more predictable clinical workflows and stable demand for veterinary products.
3. Germany is playing a dominant role
Germany’s veterinary industry benefits from a large pet population, strong consumer purchasing power, and a robust veterinary infrastructure. Investment in pet food, veterinary pharmaceuticals, and clinical services continues to support market growth.
The integrated nature of Germany’s pet care ecosystem reinforces its position as a leading market within Europe.
What opportunities exist for North American companies?
Europe’s veterinary market offers attractive opportunities for North American manufacturers and service providers, particularly in companion animal health.
Key factors supporting market entry include:
- Stable long‑term demand driven by pet ownership trends
- Growing emphasis on preventive and chronic care
- Strong veterinary professional networks
- Mature distribution and regulatory frameworks
However, Europe is not a single market. Successful expansion requires localisation by country, understanding regulatory requirements, and selecting the right distribution or commercial partners.
Key takeaways
- The European veterinary industry is one of the world’s largest and most mature animal health markets
- Growth is driven by rising pet ownership, pet humanisation, and longer animal lifespans
- Companion animal care is the fastest‑growing and most commercially attractive segment
- Preventive care is now central to veterinary practice across Europe
- Germany, France, the United Kingdom, and Spain remain the most important markets
- Europe offers strong opportunities for international companies, but requires country‑specific strategies
Sources: European Pet Food Federation (FEDIAF), European Medicines Agency (EMA), European Commission, Statista
Written by the MedTech & Life Sciences team at EuroDev.
FAQ's
-
Growth is driven by rising pet ownership, increased spending on animal welfare, longer pet lifespans, and a stronger focus on preventive healthcare across Europe.
-
While livestock remains important, companion animal care is the fastest‑growing and most commercially attractive segment in many European countries.
-
Germany, France, the United Kingdom, and Spain are among the largest and most mature veterinary markets, supported by strong purchasing power and well‑developed veterinary infrastructures.
-
Veterinary medicines and products are regulated at both EU and national levels, requiring compliance with specific authorisation, distribution, and pharmacovigilance rules.
-
Preventive care such as vaccinations, parasite control, and wellness programmes is now a central part of veterinary practice, supporting predictable long‑term demand.
Category
Related articles
-
MDR vs. FDA 510(k): Where U.S. Playbooks Break in Europe (and How to Fix Them)
Last updated: 2 March 2026Learn the key differences between FDA 510(k) and EU MDR, including classification changes, clinical...
Read more -
Expanding Non-Invasive Monitoring Tech into Europe: A Path for North American Innovators
Last updated: 26 August 2025Europe’s healthcare systems need scalable, non-invasive monitoring tools. Discover key...
Read more -
Navigating the European Market: Challenges and Opportunities for American Medical Companies
Last updated: 23 July 2025Europe’s medical device market offers huge growth potential for American MedTech companies, but...
Read more

